Suchergebnisse - "Hayden, Frederick G"

PubPharm (361)

21

Respiratory Syncytial Virus Antivirals : Problems and Progress

enthalten in: The Journal of infectious diseases | 2020

von Hayden, F. | Whitley, R.

CommentOn: J Infect Dis. 2020 Oct 1;222(9):1468-1477. - PMID 31971597

22

Baloxavir Marboxil in Japanese Pediatric Patients With Influenza : Safety and Clinical and Virologic Outcomes

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Hirotsu, N. | Sakaguchi, H. | Sato, C. | +8

CommentIn: Clin Infect Dis. 2020 Aug 14;71(4):1092-1094. - PMID 31538179

23

Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts

enthalten in: The New England journal of medicine | 2020

von Ikematsu, H. | Hayden, F. | Kawaguchi, K. | +7

CommentIn: N Engl J Med. 2020 Jul 23;383(4):389-390. - PMID 32640147

24

Global outbreak research : harmony not hegemony

enthalten in: The Lancet. Infectious diseases | 2020

von ISARIC clinical characterisation group | Akhvlediani, T. | Ali, S. | +83

25

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

enthalten in: Frontiers of medicine | 2020

von Xu, J. | Huang, C. | Fan, G. | +17

26

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

enthalten in: Frontiers of medicine | 2020

von Xu, J. | Huang, C. | Fan, G. | +17

27

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

enthalten in: Frontiers of medicine in China | 2020

von Xu, J. | Huang, C. | Fan, G. | +17

28

Surviving Sepsis Campaign : Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

enthalten in: Critical care medicine | 2020

von Alhazzani, W. | Møller, M. | Arabi, Y. | +33

CommentIn: Crit Care. 2020 Apr 23;24(1):169. - PMID 32326959

29

Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19 : study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

enthalten in: Trials | 2020

von Wang, Y. | Zhou, F. | Zhang, D. | +22

30

Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

enthalten in: Trials | 2020

von Wang, Y. | Zhou, F. | Zhang, D. | +22